Collectively, our data indicate that Nrp-1 deficiency in CD4+Foxp3+ regulatory T cells in combination with increased Th1 and Th17 cell immunity results in decreased tumor growth, although elevated expression of Tregs is detected in IL-10−/− B16/F10 mice. This evidence concerns the gene NRP1 and neoplasm.